Aims and Scope of American Journal of Hematology
American Journal of Hematology is an academic journal devoted to the coverage of blood diseases. It has been published since 1976.
Key Metrics
CiteScore 

13.4
Eigenfactor 

0.01 - 0.05
H-Index 

121
Impact Factor 

10 - 15
Scite Index 

0.88 5-Year SI

SJR 

Q1Hematology

SNIP 

2.9
Recommended pre-submission checks
Powered by 

Topics Covered on American Journal of Hematology
American Journal of Hematology Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1976 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in American Journal of Hematology
Extended Cancer Spectrum in Adults With Telomere Biology Disorders: Insights From a 113-Patient Single-Center Cohort.
- 1 Sep 2026
- American journal of hematology
Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.
- 1 Sep 2026
- American journal of hematology
Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.
- 1 Sep 2026
- American journal of hematology
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.
- 1 Sep 2026
- American journal of hematology
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.
- 1 Sep 2026
- American journal of hematology
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in1st Line Mantle Cell Lymphoma.
- 1 Sep 2026
- American journal of hematology
Extended Cancer Spectrum in Adults With Telomere Biology Disorders: Insights From a 113-Patient Single-Center Cohort.
- 1 Sep 2026
- American journal of hematology
Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.
- 1 Sep 2026
- American journal of hematology
Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.
- 1 Sep 2026
- American journal of hematology
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.
- 1 Sep 2026
- American journal of hematology
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.
- 1 Sep 2026
- American journal of hematology
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in1st Line Mantle Cell Lymphoma.
- 1 Sep 2026
- American journal of hematology